Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development

Oral Oncology

Volumn 48, Issue 9, 2012, Pages 848-852

  Feng, Jin Qiu ^a,b   Mi, Jun Guo ^c   Wu, Lan ^b   Ma, Li Wei ^d   Shi, Lin Jun ^b   Yang, Xi ^b   Liu, Wei ^b,e   Zhang, Chen Ping ^b   Zhou, Zeng Tong ^b,e  

^a Shanghai Municipal Hospital for Oral Health   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c TONGJI UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e Shanghai Key Laboratory of Stomatology   (China)

Author keywords

ABCG2; Dysplasia; Malignant transformation; Oral cancer; Oral erythroplakia; Podoplanin

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; PODOPLANIN;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; CORRELATION ANALYSIS; ERYTHROPLASIA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; MOUTH CANCER; MOUTH ERYTHROPLAKIA; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOUTH DISEASES; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES;

EID: 84865175105     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.03.015     Document Type: Article

References (36)

1. A. Zini, R. Czerninski, and H.D. Sgan-Cohen Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites J Oral Pathol Med 39 2010 299 305
2. S. Warnakulasuriya Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival Oral Oncol 46 2010 407 410
3. I. Ganly, S. Patel, and J. Shah Early stage squamous cell cancer of the oral tongue - clinicopathologic features affecting outcome Cancer 118 2012 101 111
4. T. Amagasa, M. Yamashiro, and N. Uzawa Oral premalignant lesions: from a clinical perspective Int J Clin Oncol 16 2011 5 14
5. W. Liu, Y.F. Wang, H.W. Zhou, P. Shi, Z.T. Zhou, and G.Y. Tang Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients BMC Cancer 10 2010 685
6. A. Villa, C. Villa, and S. Abati Oral cancer and oral erythroplakia: an update and implication for clinicians Aust Dent J 56 2011 253 256
7. P.A. Reichart, and H.P. Philipsen Oral erythroplakia: a review Oral Oncol 41 2005 551 561
8. G.Z. Qin, J.Y. Park, S.Y. Chen, and P. Lazarus A high prevalence of p53 mutations in pre-malignant oral erythroplakia Int J Cancer 80 1999 345 348 (Pubitemid 29019618)
9. M.W. Lingen, A. Pinto, R.A. Mendes, R. Franchini, R. Czerninski, and W.M. Tilakaratne Genetics/epigenetics of oral premalignancy: current status and future research Oral Dis 17 Suppl 1 2011 7 22
10. E. Martín-Villar, F.G. Scholl, C. Gamallo, M.M. Yurrita, M. Munoz-Guerra, and J. Cruces Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas Int J Cancer 113 2005 899 910 (Pubitemid 40096869)
11. P. Yuan, S. Temam, A. El-Naggar, X. Zhou, D.D. Liu, and J.J. Lee Overexpression of podoplanin in oral cancer and its association with poor clinical outcome Cancer 107 2006 563 569 (Pubitemid 44107217)
12. M. Kreppel, M. Scheer, U. Drebber, L. Ritter, and J.E. Zöller Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations Virchows Arch 456 2010 473 482
13. A. Bolzoni Villaret, A. Schreiber, F. Facchetti, S. Fisogni, S. Lonardi, and D. Lombardi Immunostaining patterns of CD31 and podoplanin in previously untreated advanced oral/oropharyngeal cancer: prognostic implications Head Neck 32 2010 786 792
14. L. Vormittag, D. Thurnher, S. Geleff, J. Pammer, G. Heiduschka, and M. Brunner Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy Int J Radiat Oncol Biol Phys 73 2009 913 918
15. J.P. Rodrigo, D. García-Carracedo, M.V. González, G. Mancebo, M.F. Fresno, and J. García-Pedrero Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas Mol Cancer 9 2010 48
16. G.F. Huber, F.R. Fritzsche, L. Züllig, M. Storz, and N. Graf K Haerle S, et al. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx Int J Cancer 129 2011 1404 1409
17. A. Funayama, J. Cheng, S. Maruyama, M. Yamazaki, T. Kobayashi, and M. Syafriadi Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas Pathobiology 78 2011 171 180
18. C. Margaritescu, M. Raica, D. Pirici, C. Simionescu, L. Mogoanta, and A.C. Stinga Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study Histol Histopathol 25 2010 701 711
19. M. Kreppel, U. Drebber, I. Wedemeyer, H.T. Eich, T. Backhaus, and J.E. Zoller Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy Oral Oncol 47 2011 873 878
20. H. Kawaguchi, A.K. El-Naggar, V. Papadimitrakopoulou, H. Ren, Y.H. Fan, and L. Feng Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy J Clin Oncol 26 2008 354 360 (Pubitemid 351171684)
21. P. Shi, W. Liu, Z.T. Zhou, Q.B. He, and W.W. Jiang Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus Cancer Epidemiol Biomarkers Prev 19 2010 844 849
22. S. Zhou, J.D. Schuetz, K.D. Bunting, A.M. Colapietro, J. Sampath, and J.J. Morris The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype Nat Med 7 2001 1028 1034 (Pubitemid 32937383)
23. J. Wang, L.P. Guo, L.Z. Chen, Y.X. Zeng, and S.H. Lu Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line Cancer Res 67 2007 3716 3724 (Pubitemid 46762157)
24. P. Zhang, Y. Zhang, L. Mao, Z. Zhang, and W. Chen Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes Cancer Lett 277 2009 227 234
25. Y.C. Lim, S.Y. Oh, Y.Y. Cha, S.H. Kim, X. Jin, and H. Kim Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas Oral Oncol 47 2011 83 91
26. J. Song, I. Chang, Z. Chen, M. Kang, and C.Y. Wang Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling PLoS One 5 2010 e11456
27. J.E. Diestra, G.L. Scheffer, I. Catal, M. Maliepaard, J.H. Schellens, and R.J. Scheper Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material J Pathol 198 2002 213 219 (Pubitemid 35243879)
28. World Health Organization. World Health Organization international histological classification of tumours. In: Pindborg JJ, Reichart PA, Smith CJ, Van der Waal I, editors. Histological typing of cancer and precancer of the oral mucosa. Berlin: Springer; 1997. p. 25-6.
29. S.H. Chiou, C.C. Yu, C.Y. Huang, S.C. Lin, C.J. Liu, and T.H. Tsai Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma Clin Cancer Res 14 2008 4085 4095
30. L.L. Tsai, C.C. Yu, Y.C. Chang, C.H. Yu, and M.Y. Chou Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma J Oral Pathol Med 40 2011 621 628
31. S. Yanamoto, G. Kawasaki, S. Yamada, I. Yoshitomi, T. Kawano, and H. Yonezawa Isolation and characterization of cancer stem-like side population cells in human oral cancer cells Oral Oncol 47 2011 855 860
32. W. Liu, J.Q. Feng, X.M. Shen, H.Y. Wang, Y. Liu, and Z.T. Zhou Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study Cancer 118 2012 1693 1700
33. W.M. Tilakaratne, M. Sherriff, P.R. Morgan, and E.W. Odell Grading oral epithelial dysplasia: analysis of individual features J Oral Pathol Med 40 2011 533 540
34. Mishra R. Biomarkers of oral premalignant epithelial lesions for clinical application. Oral Oncol, 2012 [Epub].
35. I. van der Waal Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management Oral Oncol 46 2010 423 425
36. P. Holmstrup, P. Vedtofte, J. Reibel, and K. Stoltze Long-term treatment outcome of oral premalignant lesions Oral Oncol 42 2006 461 474